TABLE 2.
Articles Included in the Literature Review
| Author (Publication Year) | Type of Psychosocial Intervention | Outcomes Demonstrating Efficacy of the Psychosocial Intervention |
| Methadone | ||
| Chawarski et al. (2011) | Behavioral drug and HIV risk reduction counseling | HIV risk behaviors; opiate use |
| Chen et al. (2013) | Contingency management | UA; treatment attendance |
| Gerra et al. (2011) | Contingency management | Treatment retention |
| Gruber et al. (2008) | General supportive counseling | UA; self-reported heroin use; self-reported alcohol use |
| Gu et al. (2013) | General supportive counseling | Treatment attendance; treatment retention |
| Hesse and Pedersen (2008) | General supportive counseling | Treatment contacts; fewer missed appointments; social and psychiatric improvement |
| Hser et al. (2011) | Contingency management | Treatment attendance; treatment completion; UA; longest duration of abstinence |
| Kelly et al. (2012) | General supportive counseling | — |
| Kidorf et al. (2013) | Contingency management | Counseling session attendance; psychiatric medication adherence |
| Kouimtsidis et al. (2012) | Cognitive behavioral therapy | Positive appraisal; emotional discharge |
| Marsch et al. (2014) | Web-based behavioral intervention | Opioid abstinence |
| Moore et al. (2013) | Cognitive behavioral therapy | — |
| Nyamathi et al. (2011) | Motivational interviewing | Self-reported drug use |
| Stotts et al. (2012) | Acceptance and commitment therapy | Fear of detoxification |
| Buprenorphine | ||
| Brigham et al. (2014) | Community reinforcement and family training | Treatment retention; reduction in opioid and other drug use |
| Fiellin et al. (2013) | Cognitive behavioral therapy | Physician management session attendance* |
| Katz et al. (2011) | Intensive role induction | Counseling sessions attendance; Detoxification completion; treatment retention; counselor rapport |
| Ling et al. (2013) | Cognitive behavioral therapy | Perceived behavioral treatment effectiveness |
| Contingency management | ||
| Mitchell et al. (2013) | Level of care (IOP vs OP) | — |
| Moore et al. (2012) | Cognitive behavioral therapy | — |
| Ruetsch et al. (2012) | Telephonic patient support system | Medication compliance; reduced opioid use; 12-step/self-help group attendance |
| Weiss et al. (2011) | General opioid dependence counseling | — |
| Oral naltrexone | ||
| Carpenter et al. (2009) | Behavioral naltrexone therapy | Treatment retention |
| Dunn et al. (2013) | Contingency management | UA; treatment completion |
| Nunes et al. (2006) | Behavioral naltrexone therapy | Treatment retention; weeks treatment completed; treatment attendance |
| Injectable naltrexone | ||
| DeFulio et al. (2012) | Contingency management | Number of injections; treatment retention; treatment completion |
| Everly et al. (2011) | Contingency management | Number of injections; treatment retention |
*Between-group difference favoring the control condition.
HIV, human immunodeficiency virus; IOP, intensive outpatient treatment; OP, outpatient treatment; UA, urinalysis.